NL-OMON53894招募中不适用
Selective Control Assessment of the Lower Extremities to probe the increased metabolic cost of walking after Stroke - SCALEStroke
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Individuals post stroke (n = 12)
- •- Diagnosis of stroke at least 6 months prior to testing.
- •- Age between 18 and 75 years old.
- •- Able to walk independently for a minimum of 6 minutes without an assistive
- •device, manual assistance or walking aids.
- •- Paresis on one side of the body (hemiparesis).
- •Able-bodied young adults (n = 12)
- •- Age between 18 and 25 years old.
- •Able- bodied older adults (n = 12)
- •- Age between 50 and 75 years old.
排除标准
- •Individuals post stroke (n = 12)
- •- Unable to understand the study instructions in Dutch.
- •- Unable to execute the study instructions.
- •- Having received a botulinum toxin injection in the lower extremities within
- •12 weeks prior to testing.
- •- Indications of orthopaedic, neurological, cardiorespiratory and behavioral
- •conditions other than stroke that may affect gait.
- •Healthy young and older adults (2 x n = 12)
- •- Unable to understand the study instructions in Dutch.
- •- Indications of orthopaedic, neurological, cardiorespiratory and behavioral
- •conditions that may affect gait.
研究者
相似试验
已完成
不适用
on-randomized control study of the evaluation for the switching entecavir to tenofovir alafenamide fumarate in patients with chronic HBV infectiochronic HBV infectionJPRN-UMIN000032728Kitasato University School of Medicine300
招募中
不适用
assess the result of Nurse based Structured Telephonic followup on Heart failure ManagementCTRI/2018/06/014603Research section
已完成
1 期
A study to assess effectivness of physical exercises diet modification and screen time on heignt and weight for school children studying in government schoolsCTRI/2018/01/011351INE300
招募中
不适用
Evaluation of different treatment thresholds in a clinical pathway for children with acute asthmaasthma exacerbationacute asthma10006436NL-OMON50952Martini Ziekenhuis130
进行中（未招募）
1 期
A Phase 2a, Randomized, Active-Comparator-Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Individuals With Nonalcoholic Fatty Liver Diseaseonalcoholic Fatty Liver DiseaseMedDRA version: 22.0Level: PTClassification code 10082249Term: Nonalcoholic fatty liver diseaseSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2020-005136-30-ITMERCK SHARP & DOHME CORP. UNA SUSSIDIARIA DI MERCK & CO. INC.130